ERX-208

N/A

Report date: 2026/04/13 20:02:18
NME

Base Information

Drug NameERX-208
Drug Alias NameERX-208
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysosomal acid lipase/cholesteryl ester hydrolase inhibitors
TargetsLysosomal acid lipase/cholesteryl ester hydrolase
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Texas System
China Registration ClassN/A

Develop Information

Active CompaniesEtiraRx Inc (d/b/a etira)University of Texas Southwestern Medical CenterUT Health San Antonio +[4] 
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A